Srpski arhiv za celokupno lekarstvo 2016 Volume 144, Issue 3-4, Pages: 146-150
https://doi.org/10.2298/SARH1604146B
Full text ( 181 KB)
Cited by
Comparison of the efficiency of clomiphene citrate and letrozole in combination with metformin in moderately obese clomiphene citrate - resistant polycystic ovarian syndrome patients
Bjelica Artur (Faculty of Medicine, Novi Sad + Clinical Center of Vojvodina, Department of Obstetrics and Gynecology, Novi Sad)
Trninić-Pjević Aleksandra (Faculty of Medicine, Novi Sad + Clinical Center of Vojvodina, Department of Obstetrics and Gynecology, Novi Sad)
Mladenović-Segedi Ljiljana (Faculty of Medicine, Novi Sad + Clinical Center of Vojvodina, Department of Obstetrics and Gynecology, Novi Sad)
Ćetković Nenad (Faculty of Medicine, Novi Sad + Clinical Center of Vojvodina, Department of Obstetrics and Gynecology, Novi Sad)
Petrović Đorđe (Faculty of Medicine, Novi Sad + Clinical Center of Vojvodina, Department of Obstetrics and Gynecology, Novi Sad)
Introduction. Polycystic ovary syndrome is the most common endocrinopathy in
women of reproductiveage. Therapy for those who want to get pregnant involves
ovulation induction using clomiphene citrate, metformin, letrozole and
gonadotropins. Objective. The aim of the study was to compare the efficacy of
combinations of clomiphene citrate-metformin and letrozole-metformin in obese
patients who are resistant to clomiphene citrate alone. Methods. The
investigation was conducted as a retrospective study involving 60 moderately
obese patients with polycystic ovary syndrome. Thirty-one of them received
the clomiphene citrate-metformin, and 29 letrozole-metformin therapy.
Stimulation was carried out for the procedures of intrauterine insemination
(IUI). Results. The age of patients, duration of infertility, and body mass
index in both groups were similar. There was statistically significant
difference in the thickness of the endometrium in favor of the group having
the letrozole-metformin therapy (8.9 ± 1.7 mm) compared with the group
receiving the clomiphene citrate-metformin treatment (6.3 ± 1.3 mm). The
number of follicles was not statistically significantly different. Pregnancy
rate in the first cycle of IUI in the clomiphene citrate group was 6.4%, and
17.2% in the letrozole group, which also was not statistically different.
After the third IUI cycle, the pregnancy rate was significantly higher in the
letrozole group (20.6%), while in the clomiphene citrate group it was (9.6%).
Conclusion. This retrospective study demonstrated the advantages of the use
of letrozole over clomiphene citrate in combination with metformin in
moderately obese patients with polycystic ovary syndrome who are resistant to
stimulation with clomiphene citrate alone.
Keywords: clomiphene citrate, letrozole, polycystic ovarian syndrome